F891-1421 Screening compound: 1-(1-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-3-yl]sulfonyl}piperidine-4-carbonyl)-4-phenylpiperazine

F891-1421 Screening compound: 1-(1-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-3-yl]sulfonyl}piperidine-4-carbonyl)-4-phenylpiperazine
F891-1421 Screening compound: 1-(1-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-3-yl]sulfonyl}piperidine-4-carbonyl)-4-phenylpiperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound F891-1421
1-(1-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-3-yl]sulfonyl}piperidine-4-carbonyl)-4-phenylpiperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F891-1421

Molecular Formula

C24H29N5O4S2 (C24 H29 N5 O4 S2)

Compound Name

1-(1-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-3-yl]sulfonyl}piperidine-4-carbonyl)-4-phenylpiperazine

IUPAC name

1-(1-{[2-methyl-5-(5-methyl-124-oxadiazol-3-yl)thiophen-3-yl]sulfonyl}piperidine-4-carbonyl)-4-phenylpiperazine

SMILES

Cc(sc(-c1noc(C)n1)c1)c1S(N(CC1)CCC1C(N(CC1)CCN1c1ccccc1)=O)(=O)=O

InChI

InChI=1S/C24H29N5O4S2/c1-17-22(16-21(34-17)23-25-18(2)33-26-23)35(31,32)29-10-8-19(9-11-29)24(30)28-14-12-27(13-15-28)20-6-4-3-5-7-20/h3-7,16,19H,8-15H2,1-2H3

InChI Key

WYGGCHSCKNKDLL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27202033

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

515.66

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.427

Distribution Coefficient, logD

3.427

Water Solubility, LogSw

-3.63

Polar Surface Area

83.782

Acid Dissociation Constant (pKa)

23.63

Base Dissociation Constant (pKb)

3.55

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.80

F891-1421 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Targeted Diversity Library (40567 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with F891-1421 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F891-1421?
Check Price and Availability of F891-1421, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F891-1421 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F891-1421
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F891-1421
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F891-1421 available by request